Overview (18 Sep 2026)
Zenotech Laboratories Ltd
ZENOTECH
INE486F01012

Pharmaceuticals
-0.76

Prev. Close
Previous Close
45
Current Close
44.24
Current High
45.88
Current Low
44.1
52 Week High
54.87
52 Week Low
33.55
Resistance 1
45.38
Resistance 2
46.52
Support 1
43.60
Support 2
41.82
Std Deviation
2.37%
DMA 200
45.11
DMA 50
45.38
DMA 20
45.39
Fundamentals and Ratios
Standalone
Trailing EPS
-0.18
Forwad EPS
-0.36
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
-2.92
Mkt. Cap (Cr)
Market Cap (Cr)
270
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
35.10
Book Value
11.22
P/BV Ratio
3.94
ROCE(%)
2.00
ROE
2.00

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue9.68.8711.8310.238.6439.56
Other Income1.451.611.451.711.596.36
Total Income11.0510.4813.2811.9410.2345.92
Interest0.000.000.000.000.000.00
Expenditure-11.65-11.47-10.39-10.73-8.90-41.54
PBDT0.000.000.000.000.000.00
Depreciation-1.90-1.76-1.80-1.78-1.77-7.11
PBT-0.60-0.942.591.261.284.19
Tax0.15-2.22-0.66-2.10-0.20-5.26
Equity0.000.000.000.000.000.00
OPM-6.26-10.5621.8912.2914.789.00
Net Profit-0.6-3.151.93-0.840.99-1.07
NPM-6.26-35.5416.29-8.1811.46-2
EPS-0.07-0.520.320.140-0.18
Consolidated
TypeFY24-25
Revenue38.9757
Other Income5.62
Total Income44.60
Interest0.00
Expenditure-35.83
PBDT0.00
Depreciation-6.96
PBT10.69
Tax-5.08
Equity61.03
OPM23.98
Net Profit5.61
NPM12.59
EPS0.92
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings